Andrea S. Blevins Primeau, PhD, MBA

Andrea S. Blevins Primeau, PhD, MBA, is a freelance medical writer and editor based in central Pennsylvania. She enjoys writing about a variety of topics including oncology, cardiovascular disease, and autoimmune disorders. Previously, she conducted research investigating the role of pharmacogenetics on the efficacy of oncologic therapies.

Most Recent Articles by Andrea S. Blevins Primeau, PhD, MBA

Amygdalin and Cancer

Amygdalin and Cancer

By

While some in vitro data suggests anticancer activity, animal and in-human studies fail to show efficacy and the risk of cyanide toxicity make amygdalin not recommended for use.

Pediatric CML: Life-Long Considerations With TKI Therapy

Pediatric CML: Life-Long Considerations With TKI Therapy

By

Because most patients with CML are adults, there are no established treatment guidelines and many clinicians apply adult guidelines to their pediatric patients.

Cannabis and Cancer

Cannabis and Cancer

By

Cannabis and its synthetic cannabinoids have been studied for medicinal properties across multiple disease states.

Essential Oils and Cancer

Essential Oils and Cancer

By

In-human studies have evaluated the use of EOs in a supportive role, and though EOs appear to have some efficacy in this setting, larger studies are needed to confirm their effects.

Cascara and Cancer

Cascara and Cancer

By

Cascara use is not recommended because there are insufficient data for establishing its safety, and there have been reports of liver injury with high doses.

More Articles by Andrea S. Blevins Primeau, PhD, MBA

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs